News/Events
Patients living with Crohn’s and colitis to benefit from £5m grant for a new data research hub based in Cambridge
£5m grant awarded by Health Data Research UK (HDR UK) to establish a health data research hub for inflammatory bowel disease (IBD) following a successful bid led by Eastern AHSN and Cambridge Read more
A life of low cholesterol and BP slashes heart and circulatory disease risk
Modest and sustained decreases in blood pressure and cholesterol levels reduces the lifetime risk of developing fatal heart and circulatory diseases, such as heart attack and stroke, according to research. Read more
World Health Organisation CVD risk charts updated using Cambridge-led research
Research revising the World Health Organisation (WHO) cardiovascular disease (CVD) risk prediction charts to aid efforts to reduce the burden of CVD, especially in low- and middle-income countries, has been published by The Lancet Global Health.Read more
New stem cell combination could help to repair damaged hearts
A combination of heart cells derived from human stem cells could be the answer to developing a desperately-needed treatment for heart failure, according to new research part-funded by the British Heart Foundation (BHF), Read more
No microbiome in human placenta: Cambridge researchers’ paper published in Nature
World-leading science journal Nature has published a paper from the Department of Obstetrics and Gynaecology at the University of Cambridge. Entitled “Human placenta has no microbiome but can contain potential pathogens”, the paper Read more
Cambridge University Hospitals revealed as country’s top performing trust for increasing research
Cambridge University Hospitals NHS Foundation Trust (CUH) has been revealed as England’s top performing trust for increasing research in the annual National Institute for Health Research Read more
Cambridge researchers take top awards
Two NIHR Cambridge BRC researchers have won top awards from the The American Diabetes Association. Read more
Study shows that in HER2 positive early breast cancer 6 months treatment with Herceptin is as good as 12 months for preventing cancer return
NIHR Cambridge BRC and CRUK breast cancer study could help patients and save millions of pounds worldwide.Read more
World-leading genome study spells hope for sick babies
A Cambridge-based study has shown that the diagnosis and treatment of some of the most critically ill babies can be improved by sequencing their whole genome.Read more
Virtual reality can spot navigation problems in early Alzheimer’s disease
Virtual reality (VR) can identify early Alzheimer’s disease more accurately than ‘gold standard’ cognitive tests currently in use, suggests new research.Read more
Additional routine ultrasounds benefit mothers and babies, and could save costs, study finds
A study led by researchers at the University of Cambridge and published this week in PLOS Medicine has found that offering universal late pregnancy ultrasounds at 36 weeks’ gestation eliminates Read more
Discovery of genetic variants that protect against obesity and type 2 diabetes could lead to new weight loss medicines
Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, suggests new research from the University of Cambridge.Read more
Discover more
If you would like more information about the NIHR Cambridge BRC, please contact us.